Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 20Plasma cell 19Other hematologic neoplasm 16Thoracic 3Myeloid 2Tumor-Agnostic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Leukemia, Biphenotypic, Acute 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

fludarabine 33Specimen Handling 31Azacitidine 31venetoclax 30Cyclophosphamide 29Biopsy 25fludarabine phosphate 23Whole-Body Irradiation 19Cytarabine 19Mycophenolic Acid 18Busulfan 18ruxolitinib 17Tacrolimus 16Decitabine 16asciminib 15Injections 15Melphalan 14Granulocyte Colony-Stimulating Factor 13decitabine and cedazuridine drug combination 12X-Rays 12Stem Cell Transplantation 12Magnetic Resonance Spectroscopy 11Cyclosporine 11Sirolimus 10Peripheral Blood Stem Cell Transplantation 10Thiotepa 9Filgrastim 9nilotinib 7Methotrexate 7Imatinib Mesylate 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
dexamethasone acetate × Myeloid × 90 days × Clear all
NCT04216524 2026-04-14

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

M.D. Anderson Cancer Center

Phase 2 Recruiting
40 enrolled
Myeloid

Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT05292664 2026-03-12

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Dana-Farber Cancer Institute

Phase 1 Recruiting
30 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡